Texas Permanent School Fund’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,237
| Closed | -$118K | – | 1534 |
|
|
2023
Q1 | $118K | Buy |
11,237
+2,854
| +34% | +$86.3K | ﹤0.01% | 1517 |
|
|
2022
Q4 | $284K | Sell |
8,383
-564
| -6% | -$27.3K | ﹤0.01% | 1456 |
|
|
2022
Q3 | $429K | Buy |
8,947
+17
| +0.2% | +$1.01K | 0.01% | 1382 |
|
|
2022
Q2 | $509K | Buy |
8,930
+207
| +2% | +$13.1K | 0.01% | 1355 |
|
|
2022
Q1 | $705K | Sell |
8,723
-148
| -2% | -$21.9K | 0.01% | 1300 |
|
|
2021
Q4 | $1.8M | Sell |
8,871
-193
| -2% | -$41.9K | 0.02% | 967 |
|
|
2021
Q3 | $2.44M | Buy |
9,064
+7
| +0.1% | +$1.68K | 0.03% | 786 |
|
|
2021
Q2 | $2.33M | Sell |
9,057
-17
| -0.2% | -$4.71K | 0.03% | 828 |
|
|
2021
Q1 | $2.72M | Sell |
9,074
-529
| -6% | -$165K | 0.03% | 700 |
|
|
2020
Q4 | $2.45M | Sell |
9,603
-1,539
| -14% | -$398K | 0.03% | 720 |
|
|
2020
Q3 | $2.77M | Buy |
11,142
+1,767
| +19% | +$556K | 0.04% | 578 |
|
|
2020
Q2 | $3.26M | Sell |
9,375
-615
| -6% | -$192K | 0.05% | 424 |
|
|
2020
Q1 | $2.67M | Buy |
9,990
+1,968
| +25% | +$609K | 0.05% | 451 |
|
|
2019
Q4 | $2.6M | Buy |
8,022
+5,865
| +272% | +$1.7M | 0.04% | 585 |
|
|
2019
Q3 | $589K | Sell |
2,157
-84
| -4% | -$30.8K | 0.01% | 1257 |
|
|
2019
Q2 | $1.2M | Sell |
2,241
-17
| -0.8% | -$8.52K | 0.02% | 978 |
|
|
2019
Q1 | $1.14M | Sell |
2,258
-63
| -3% | -$37.3K | 0.02% | 1006 |
|
|
2018
Q4 | $1.14M | Sell |
2,321
-260
| -10% | -$157K | 0.02% | 932 |
|
|
2018
Q3 | $2.36M | Sell |
2,581
-40
| -2% | -$34.1K | 0.03% | 665 |
|
|
2018
Q2 | $1.92M | Sell |
2,621
-151
| -5% | -$174K | 0.03% | 786 |
|
|
2018
Q1 | $4.42M | Sell |
2,772
-4,324
| -61% | -$5.57M | 0.06% | 340 |
|
|
2017
Q4 | $6.36M | Sell |
7,096
-512
| -7% | -$303K | 0.08% | 244 |
|
|
2017
Q3 | $2.74M | Buy |
7,608
+56
| +0.7% | +$17.5K | 0.04% | 629 |
|
|
2017
Q2 | $2.21M | Buy |
7,552
+127
| +2% | +$36.7K | 0.03% | 732 |
|
|
2017
Q1 | $2.61M | Sell |
7,425
-6
| -0.1% | -$1.35K | 0.03% | 648 |
|
|
2016
Q4 | $1.37M | Buy |
7,431
+487
| +7% | +$99K | 0.02% | 971 |
|
|
2016
Q3 | $1.79M | Sell |
6,944
-2
| -0% | -$515 | 0.02% | 826 |
|
|
2016
Q2 | $1.48M | Sell |
6,946
-265
| -4% | -$59.2K | 0.02% | 887 |
|
|
2016
Q1 | $1.49M | Sell |
7,211
-149
| -2% | -$28.6K | 0.02% | 903 |
|
|
2015
Q4 | $1.86M | Buy |
7,360
+65
| +0.9% | +$13.4K | 0.02% | 815 |
|
|
2015
Q3 | $1.2M | Sell |
7,295
-145
| -2% | -$25.6K | 0.02% | 1017 |
|
|
2015
Q2 | $1.4M | Buy |
+7,440
| New | +$1.28M | 0.02% | 1002 |
|
Other funds holding NKTR
DTC
MAM
SCM
Texas Permanent School Fund's NKTR Position: Q2 2023 in Review
Texas Permanent School Fund sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 11,237 shares — an estimated $118K sold.
Texas Permanent School Fund first reported a position in NKTR in Q2 2015 and held it in 32 quarters. The position peaked at $6.36M in Q4 2017. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.
- Texas Permanent School Fund reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
- Texas Permanent School Fund sold 11,237 Nektar Therapeutics shares in Q2 2023, an estimated $118K.
- Texas Permanent School Fund first reported a position in Nektar Therapeutics in Q2 2015 and held it in 32 quarters.
- Texas Permanent School Fund's Nektar Therapeutics position peaked at $6.36M in Q4 2017.
- 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.
Based on Texas Permanent School Fund's 13F filing for Q2 2023, filed 7 Aug 2023.